Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
137.48
-0.22 (-0.16%)
Official Closing Price
Updated: 6:30 PM EDT, Sep 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,936,686
Open
138.14
Bid (Size)
137.31 (1,000)
Ask (Size)
137.88 (500)
Prev. Close
137.70
Today's Range
137.30 - 139.45
52wk Range
121.57 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.47%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2025 R&D Spending And Intensity Benchmarks
Today 10:03 EDT
Via
PRLog
Topics
Supply Chain
Stock Market Today, Sept. 8: Stocks Slide Amid Surging Oil Prices, Persistent Geopolotical Tenisons
↗
September 08, 2026
Crude oil pushed toward $100 per barrel amid Middle East conflict and U.S.-Canada trade friction, today, Sept. 8, 2026.
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks
World Trade
Performance
YTD
-0.8%
-0.8%
1 Month
-12.3%
-12.3%
3 Month
-7.8%
-7.8%
6 Month
-14.9%
-14.9%
1 Year
+6.8%
+6.8%
More News
Read More
A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower
↗
September 08, 2026
Via
Benzinga
Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling
↗
September 08, 2026
Via
Benzinga
Novartis (NYSE:NVS): A Dividend Quality Play for Income Investors
↗
August 21, 2026
Via
Chartmill
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts
↗
July 29, 2026
Via
Chartmill
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma
↗
September 08, 2026
Via
Investor's Business Daily
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
↗
September 08, 2026
Via
Benzinga
Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners
↗
September 08, 2026
Via
Benzinga
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday
↗
September 08, 2026
Via
Benzinga
Novartis, Ionis Tumble On Surprise Flop For Heart Drug
↗
September 04, 2026
Via
Investor's Business Daily
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths
↗
September 04, 2026
Via
Benzinga
Topics
Death
The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win
↗
September 01, 2026
Via
Benzinga
Tuesday's session: gap up and gap down stocks
↗
September 01, 2026
Via
Chartmill
Why Novartis Just Surged 6%, Eyeing A Breakout
↗
September 01, 2026
Via
Investor's Business Daily
Hear from a prostate cancer patient about the one test more men should ask for
August 30, 2026
Via
NewsUSA
VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
↗
August 23, 2026
Via
MarketBeat
Topics
ETFs
Breakfast News: A Conversation With Ionis CEO
↗
August 22, 2026
Via
The Motley Fool
Topics
ETFs
World Trade
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
↗
August 18, 2026
Via
The Motley Fool
Topics
ETFs
PPH vs. IYH: Which Healthcare Fund Is the Better Buy?
↗
August 18, 2026
Via
The Motley Fool
Topics
ETFs
This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
↗
August 17, 2026
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Stocks
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better.
↗
August 16, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Vanguard Is Bullish on Developed Markets Outside the U.S. -- But How Can You Buy Them? These 2 ETFs Can Help.
↗
August 14, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?
↗
August 12, 2026
Via
The Motley Fool
Topics
ETFs
3 Dividend Stocks to Buy for a Lifetime of Passive Income
↗
July 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 137.48
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/09/26 06:30 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.